350: Pharma tariffs, and a 'sunshine day' for biotech stocks
The Readout Loud
00:00
A Turnaround for Biotech
This chapter reflects on a positive shift in the biotech industry, discussing the rise in stocks and improved investor sentiment following recent FDA approvals. The speakers also explore the implications of tariff policies on the sector, contributing to a cautious yet optimistic atmosphere as they celebrate the milestone of 350 podcast episodes.
Transcript
Play full episode
